Rossby Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4K Sell
97
-540
-85% -$92.8K ﹤0.01% 982
2026
Q1
$108K Buy
637
+601
+1,669% +$103K 0.02% 523
2025
Q4
$6.08K Buy
+36
New +$5.85K ﹤0.01% 1058

Other funds holding IBB

Rossby Financial's IBB Position: Q2 2026 in Review

Rossby Financial reduced its iShares Biotechnology ETF (IBB) stake by 85% in Q2 2026, selling an estimated $92.8K and leaving 97 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Rossby Financial first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. The position peaked at $108K in Q1 2026. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Rossby Financial held 97 shares of iShares Biotechnology ETF worth $18.4K as of Q2 2026.
  • Rossby Financial sold 540 iShares Biotechnology ETF shares in Q2 2026, an estimated $92.8K.
  • iShares Biotechnology ETF made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #982 holding.
  • Rossby Financial first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • Rossby Financial's iShares Biotechnology ETF position peaked at $108K in Q1 2026.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.